Diagnostic role of tumor markers

Torre, Francisco Javier Mérida de la; Campoy, Elvira Eva Moreno

doi:10.1016/j.medcle.2018.10.016

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many studies in some adenocarcinoma of the digestive and reproductive tracts revealed that the tumor markers had a strong correlation with prognosis and recurrence. [15][16][17] However, scarce studies assessed the prognostic prediction of serum CEA, CA125, and CA19-9 levels in cervical adenocarcinoma patients. As the limitations mentioned above, we designed a tumormarker-based classification stratified by serum CEA, CA125, and CA19-9 levels, sought to explore the prognosis and recurrence patterns of each stratification and attempted to identify the possible use of such a tumor-marker-based method to be a preoperative prognostic predictor of cervical adenocarcinoma.…”

Section: Introductionmentioning

confidence: 99%

Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma

Zhang,

Li,

et al. 2023

Int J Biol Markers

View full text Add to dashboard Cite

Objective There is a lack of research evaluating the effect of tumor markers for prognosis in cervical adenocarcinoma. We aimed to develop and validate a preoperative tumor-marker-based model including clinicopathological factors to clarify the prognostic value of endocervical adenocarcinoma. Methods A total of 572 patients with cervical adenocarcinoma who were staged at the International Federation of Gynecology and Obstetrics (FIGO) IA–IIA were reviewed retrospectively. Preoperative serum carcinoembryonic antigen (CEA), carbohydrate antigen (CA)-125 and CA19-9 levels were measured. The survival and recurrence patterns were analyzed according to the tumor-marker-related stratification. The predictive values of biomarkers and clinical variables were assessed with Cox regression and competing risk models. Results Patients with elevated preoperative tumor markers had evidently poor overall survival and recurrence-free survival. The triple-elevated tumor marker (TETM) subgroup had the worst overall survival and progression-free survival than the triple-negative tumor marker (TNTM) subgroup and the single-elevated tumor marker (SETM) subgroup. The most important predictors for overall survival were elevated tumor markers, FIGO-stage, tumor differentiation, lymphovascular space invasion (LVSI) and lymph nodes metastasis. The most important predictors for recurrence-free survival were elevated tumor markers, FIGO-stage, tumor differentiation, LVSI and deep stromal invasion. Stratified analysis showed that elevated CA-125 and CA19-9 were significantly associated with postoperative distant metastasis. A decision curve analysis confirmed that a combination of tumor markers as predictors significantly outperformed the other common predictors used (FIGO-stage, intermediate and high-risk factors, tumor differentiation, lymph nodes). Conclusions Elevated preoperative serum CEA, CA-125, and CA19-9 levels exhibited poor overall survival and recurrence-free survival in cervical adenocarcinoma patients. Combined preoperative serum CA-125 and CA19-9 independently predicted distant metastasis in patients with endocervical adenocarcinoma.

show abstract

Section: Introductionmentioning

confidence: 99%